[1] World Health Organization. Cardiovascular diseases (CVDs) [OL]. (2017-05-17)[2018-07-04]. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). [2] World Health Organization. World Health Statistics 2017: Monitoring health for the SDGs [OL]. (2017-05-17)[2018-07-04]. http://www.who.int/ gho/ publications/world_health_statistics/2017/en. [3] 陈伟伟, 高润霖, 刘力生, 等. 《中国心血管病报告 2017》概要[J]. 中国循环杂志, 2018, 33(1): 1-8. [4] Libby P. Changing concepts of atherogenesis [J]. Journal of internal medicine, 2000, 247(3): 349-358. [5] Lusis A J. Atherosclerosis [J]. Nature, 2000, 407(6801): 233-241. [6] 李露, 吕佳倩, 江承佳, 等. 茶多酚对心血管保护作用的研究进展[J]. 食品科学, 2016, 37(19): 283-288. [7] Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s [J]. Nature, 1993, 362(6423): 801-809. [8] Sasazuki S, Kodama H, Yoshimasu K, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women [J]. Annals of epidemiology, 2000, 10(6): 401-408. [9] Sano J, Inami S, Seimiya K, et al. Effects of green tea intake on the development of coronary artery disease [J]. Circulation Journal, 2004, 68(7): 665-670. [10] Wen W, Xiang Y B, Zheng W, et al. The association of alcohol, tea, and other modifiable lifestyle factors with myocardial infarction and stroke in Chinese men [J]. CVD prevention and control, 2008, 3(3): 133-140. [11] Kim W, Jeong M H, Cho S H, et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers [J]. Circulation Journal, 2006, 70(8): 1052-1057. [12] Coimbra S, Santos-Silva A, Rocha-Pereira P, et al. Green tea consumption improves plasma lipid profiles in adults [J]. Nutrition research, 2006, 26(11): 604-607. [13] Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans [J]. Obesity, 2007, 15(6): 1473-1483. [14] Wang Q M, Gong Q Y, Yan J J, et al. Association between green tea intake and coronary artery disease in a Chinese population [J]. Circulation Journal, 2010, 74(2): 294-300. [15] Widlansky M E, Hamburg N M, Anter E, et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease [J]. Journal of the American College of Nutrition, 2007, 26(2): 95-102. [16] Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study [J]. Jama, 2006, 296(10): 1255-1265. [17] Mineharu Y, Koizumi A, Wada Y, et al. Coffee, green tea, black tea and Oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women [J]. Journal of Epidemiology Community Health, 2010, 65(3): 230-240. [18] Suzuki E, Yorifuji T, Takao S, et al. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort [J]. Annals of epidemiology, 2009, 19(10): 732-739. [19] Saito E, Inoue M, Sawada N, et al. Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan public health center-based prospective study (JPHC Study) [J]. Annals of epidemiology, 2015, 25(7): 512-518. e3. [20] Higdon J V, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions [J]. 2003, 43(1): 89-143. [21] Van den Brandt P A. Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women [J]. European journal of epidemiology, 2018, 33(2): 183-200. [22] Tian C, Huang Q, Yang L, et al. Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort [J]. Scientific Reports, 2017. https://doi.org/10.1038/srep45949. [23] Yamagata K, Xie Y, Suzuki S, et al. Epigallocatechin-3-gallate inhibits VCAM-1 expression and apoptosis induction associated with LC3 expressions in TNFα-stimulated human endothelial cells [J]. Phytomedicine, 2015, 22(4): 431-437. [24] Naito Y, Yoshikawa T. Green tea and heart health [J]. Journal of cardiovascular pharmacology, 2009, 54(5): 385-390. [25] Ludwig A, Lorenz M, Grimbo N, et al. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells [J]. Biochemical and biophysical research communications, 2004, 316(3): 659-665. [26] Li M, Liu J T, Pang X M, et al. Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages [J]. Pharmacological Reports, 2012, 64(4): 912-918. [27] Wang C J, Liu J T, Guo F. (-)-Epigallocatechin gallate inhibits endothelin-1-induced C-reactive protein production in vascular smooth muscle cells [J]. Basic & clinical pharmacology & toxicology, 2010, 107(2): 669-675. [28] Won S M, Park Y H, Kim H J, et al. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway [J]. Experimental and Molecular Medicine, 2006, 38(5): 525-534. [29] Zhang S H, Reddick R L, Piedrahita J A, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E [J]. Science, 1992, 258(5081): 468-471. [30] Chyu K Y, Babbidge S M, Zhao X, et al. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice [J]. Circulation, 2004, 109(20): 2448-2453. [31] Mika M, Kostogrys R B, Franczyk-?arów M, et al. Anti-atherosclerotic activity of catechins depends on their stereoisomerism [J]. Atherosclerosis, 2015, 240(1): 125-130. [32] Hayek T, Fuhrman B, Vaya J, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 1997, 17(11): 2744-2752. [33] Morrison M, van der Heijden R, Heeringa P, et al. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo [J]. Atherosclerosis, 2014, 233(1): 149-156. [34] Auclair S, Milenkovic D, Besson C, et al. Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study [J]. Atherosclerosis, 2009, 204(2): e21-e27. [35] Ridker P M, Hennekens C H, Roitman-Johnson B, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men [J]. The Lancet, 1998, 351(9096): 88-92. [36] Martinovic I, Abegunewardene N, Seul M, et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease [J]. Circulation Journal, 2005, 69(12): 1484-1489. [37] Chae Y J, Kim C H, Ha T S, et al. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways [J]. Cellular Physiology and Biochemistry, 2007, 20(6): 859-866. [38] Ludwig A, Lorenz M, Grimbo N, et al. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells [J]. Biochemical and Biophysical Research Communications, 2004, 316(3): 659-665. [39] Ahn H Y, Xu Y, Davidge S T. Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cells [J]. Life Sciences, 2008, 82(17/18): 964-968. [40] Nelken N A, Coughlin S R, Gordon D, et al. Monocyte chemoattractant protein-1 in human atheromatous plaques [J]. The Journal of Clinical Investigation, 1991, 88(4): 1121-1127. [41] Yu X, Dluz S, Graves D T, et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates [J]. Proceedings of the National Academy of Sciences, 1992, 89(15): 6953-6957. [42] Wang Z M, Gao W, Wang H, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits TNF-a-induced production of monocyte chemoattractant protein-1 in human umbilical vein endothelial cells [J]. Cellular Physiology and Biochemistry, 2014, 33(5): 1349-1358. [43] Ramesh E, Geraldine P, Thomas P A. Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis [J]. Chemico-Biological Interactions, 2010, 183(1): 125-132. [44] Das S, Babick A P, Xu Y J, et al. TNF-α-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy [J]. Journal of Cellular and Molecular Medicine, 2010, 14(7): 1988-1997. [45] Wheeler D S, Catravas J D, Odoms K, et al. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1β-dependent proinflammatory signal transduction in cultured respiratory epithelial cells [J]. The Journal of Nutrition, 2004, 134(5): 1039-1044. [46] Kürbitz C, Heise D, Redmer T, et al. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells [J]. Cancer Science, 2011, 102(4): 728-734. [47] Baines C P, Molkentin J D. Stress signaling pathways that modulate cardiac myocyte apoptosis [J]. Journal of Molecular and Cellular Cardiology, 2005, 38(1): 47-62. [48] Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt [J]. Journal of Molecular and Cellular Cardiology, 2005, 38(1): 63-71. [49] Armstrong S C. Protein kinase activation and myocardial ischemia/reperfusion injury [J]. Cardiovascular Research, 2004, 61(3): 427-436. [50] Yang D, Liu J, Tian C, et al. Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway [J]. Acta Pharmacologica Sinica, 2010, 31(10): 1401. [51] Takeshita K, Satoh M, Ii M, et al. Critical role of endothelial Notch1 signaling in postnatal angiogenesis [J]. Circulation Research, 2007, 100(1): 70-78. [52] Marchant D J, Boyd J H, Lin D C, et al. Inflammation in myocardial diseases [J]. Circulation Research, 2012, 110(1): 126-144. [53] Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF [J]. Oxidative Medicine and Cellular Longevity, 2015, 2015: 1-18. DOI: 10.1155/2015/610813. [54] Croquelois A, Domenighetti A A, Nemir M, et al. Control of the adaptive response of the heart to stress via the Notch1 receptor pathway [J]. Journal of Experimental Medicine, 2008, 205(13): 3173-3185. [55] Kratsios P, Catela C, Salimova E, et al. Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart [J]. Circulation Research, 2010, 106(3): 559-572. [56] Li Y, Takeshita K, Liu P Y, et al. Smooth muscle Notch1 mediates neointimal formation after vascular injury [J]. Circulation, 2009, 119(20): 2686-2692. [57] Xie H, Sun J, Chen Y, et al. EGCG attenuates uric acid-induced inflammatory and oxidative stress responses by medicating the NOTCH pathway [J]. Oxidative Medicine and Cellular Longevity, 2015, 2015: 1-10. [58] Mirzaei H, Khataminfar S, Mohammadparast S, et al. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in gastric cancer: current status and future perspectives [J]. Current Medicinal Chemistry, 2016, 23(36): 4135-4150. [59] 马兰, 张基昌, 崔燕, 等. MicroRNAs 与冠心病发生发展关系的研究进展[J]. 中国实验诊断学, 2013, 17(7): 1354-1357. [60] Albinsson S, Suarez Y, Skoura A, et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, 30(6): 1118-1126. [61] Cipollone F, Felicioni L, Sarzani R, et al. A unique microRNA signature associated with plaque instability in humans [J]. Stroke, 2011, 42(9): 2556-2563. [62] Fix L N, Shan M, Efferth T, et al. MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60 [J]. Cancer Genomics-Proteomics, 2010, 7(5): 261-277. [63] 杨红霞, 高亚, 蒋恒波, 等. EGCG通过miR-33a上调ABCA1表达减少巨噬细胞脂质蓄积[J]. 2016, 39(9): 1279-1284. [64] 江亚文. 动脉粥样硬化的研究进展[J]. 广东医学, 2003, 24(1): 88-90. [65] Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study [J]. The British Medical Journal, 1986, 293(6542): 306-307. [66] Yang T T C, Koo M W L. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion [J]. Life Sciences, 1999, 66(5): 411-423. [67] Ikeda I, Kobayashi M, Hamada T, et al. Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate [J]. Journal of Agricultural and Food Chemistry, 2003, 51(25): 7303-7307. [68] Xuan F, Jian J. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux [J]. International journal of molecular medicine, 2016, 38(1): 328-336. [69] Kajimoto O, Kajimoto Y, Yabune M, et al. Tea catechins reduce serum cholesterol levels in mild and borderline hypercholesterolemia patients [J]. Journal of Clinical Biochemistry and Nutrition, 2003, 33(3): 101-111. [70] Tsubono Y, Tsugane S. Green tea intake in relation to serum lipid levels in middle-aged Japanese men and women [J]. Annals of Epidemiology, 1997, 7(4): 280-284. [71] Tokunaga S, White I R, Frost C, et al. Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan [J]. Annals of Epidemiology, 2002, 12(3): 157-165. [72] Wu A H, Spicer D, Stanczyk F Z, et al. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormonal levels in healthy postmenopausal women [J]. Cancer Prevention Research, 2012, 5(3): 393-402. [73] Ikeda I, Imasato Y, Sasaki E, et al. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats [J]. Biochimica et Biophysica Acta, 1992, 1127(2): 141-146. [74] Imbe H, Sano H, Miyawaki M, et al. “Benifuuki” green tea, containing O-methylated EGCG, reduces serum low-density lipoprotein cholesterol and lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein B: A double-blind, placebo-controlled randomized trial [J]. Journal of Functional Foods, 2016, 25: 25-37. [75] Jin H H, Yang J L, Chung J H, et al. Hypocholesterolemic effects of green tea in cholesterol-fed rats [J]. Journal of the Korean Society of Food Science and Nutrition, 2004, 33(1): 47-51. [76] Hsu T F, Kusumoto A, Abe K, et al. Polyphenol-enriched Oolong tea increases fecal lipid excretion [J]. European Journal of Clinical Nutrition, 2006, 60(11): 1330-1336. [77] Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats [J]. Journal of Nutritional Science and Vitaminology, 1986, 32(6): 613-622. [78] Heidrich J E, Contos L M, Hunsaker L A, et al. Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster [J]. BMC Pharmacology, 2004, 4(1): 5. https://doi.org/10.1186/1471-2210-4-5. [79] Jeon S Y, Imm J Y. Lipase inhibition and cholesterol-lowering activities of laccase-catalyzed catechin polymers [J]. Food Science and Biotechnology, 2014, 23(5): 1703-1707. [80] Nakai M, Fukui Y, Asami S, et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro [J]. Journal of Agricultural and Food Chemistry, 2005, 53(11): 4593-4598. [81] Morita S. Metabolism and modification of apolipoprotein B-containing lipoproteins involved in dyslipidemia and atherosclerosis [J]. Biological and Pharmaceutical Bulletin, 2016, 39(1): 1-24. [82] Frijhoff J, Winyard P G, Zarkovic N, et al. Clinical relevance of biomarkers of oxidative stress [J]. Antioxidants & redox signaling, 2015, 23(14): 1144-1170. [83] Steinberg D, Parthasarathy S, Carew T E, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity [J]. The New England Journal of Medicine, 1989, 320(14): 915-924. [84] Steinberg D. The LDL modification hypothesis of atherogenesis: an update [J]. Journal of Lipid Research, 2009, 50(Sup 1): S376-S381 [85] Frei B, Gaziano J M. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and-independent oxidation [J]. Journal of Lipid Research, 1993, 34(12): 2135-2145. [86] Koo S I, Noh S K. Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect [J]. The Journal of nutritional biochemistry, 2007, 18(3): 179-183. [87] Chen G, Wang H, Zhang X, et al. Nutraceuticals and functional foods in the management of hyperlipidemia [J]. Critical reviews in food science and nutrition, 2014, 54(9): 1180-1201. [88] Annuzzi G, Bozzetto L, Costabile G, et al. Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial [J]. The American journal of clinical nutrition, 2013, 99(3): 463-471. [89] Yao Z, Zhang L, Ji G. Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes [J]. Journal of integrative medicine, 2014, 12(3): 135-146. [90] Upadhyay S, Dixit M. Role of polyphenols and other phytochemicals on molecular signaling [J]. Oxidative Medicine and Cellular Longevity, 2015, 2015: 1-15. http://dx.doi.org/10.1155/2015/504253. [91] Sukhbold E, Sekimoto S, Watanabe E, et al. Effects of oolonghomobisflavan a on oxidation of low-density lipoprotein [J]. Bioscience, Biotechnology, and Biochemistry, 2017, 81(8): 1569-1575. [92] Goto T, Saito Y, Morikawa K, et al. Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes [J]. British Journal of Nutrition, 2012, 107(6): 769-773. [93] 刘波静. 茶多酚对动物血清血脂和载脂蛋白水平的影响和抗氧化作用[J]. 茶叶科学, 2000, 20(1): 67-70. [94] Li P F, Dietz R, Von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell [J]. FEBS letters, 1997, 404(2/3): 249-252. [95] Li P F, Dietz R, Von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells [J]. Circulation, 1997, 96(10): 3602-3609. [96] Vacaresse N, Vieira O, Robbesyn F, et al. Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL‐induced EGF‐receptor activation [J]. British Journal of Pharmacology, 2001, 132(8): 1777-1788. [97] Devika P T, Prince P S M. Preventive effect of (-) epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted wistar rats [J]. Chemico-Biological Interactions, 2008, 172(3): 245-252. [98] Singh B N, Shankar S, Srivastava R K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications [J]. Biochemical Pharmacology, 2011, 82(12): 1807-1821. [99] Choi J S, Choi Y J, Shin S Y, et al. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK-and JAK/STAT-signaling [J]. The Journal of Nutrition, 2008, 138(6): 983-990. [100] Li H L, Huang Y, Zhang C N, et al. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and-independent signal pathways [J]. Free Radical Biology and Medicine, 2006, 40(10): 1756-1775. [101] Arai H, Berlett B S, Chock P B, et al. Effect of bicarbonate on iron-mediated oxidation of low-density lipoprotein [J]. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(30): 10472-10477. [102] Milde J, Elstner E F, Grassmann J. Synergistic inhibition of low-density lipoprotein oxidation by rutin, γ-terpinene, and ascorbic acid [J]. Phytomedicine, 2004, 11(2/3): 105-113. [103] Gutteridge J M. Lipid peroxidation and antioxidants as biomarkers of tissue damage [J]. Clinical Chemistry, 1995, 41(12): 1819-1828. [104] Potapovich A I, Kostyuk V A. Comparative study of antioxidant properties and cytoprotective activity of flavonoids [J]. Biochemistry (Moscow), 2003, 68(5): 514-519. [105] 赵秀兰, 宫爱华, 李建华, 等. 茶多酚抗动脉粥样硬化机制研究[J]. 中国公共卫生, 2003, 19(8): 930-931. [106] Jayashree G V, Krupashree K, Rachitha P, et al. Patulin Induced Oxidative Stress Mediated Apoptotic Damage in Mice, and its Modulation by Green Tea Leaves [J]. Journal of Clinical and Experimental Hepatology, 2017, 7(2): 127-134. [107] Zhu Q Y, Huang Y, Tsang D, et al. Regeneration of α-tocopherol in human low-density lipoprotein by green tea catechin [J]. Journal of Agricultural and Food Chemistry, 1999, 47(5): 2020-2025. [108] Liu Z Q, Ma L P, Zhou B, et al. Antioxidative effects of green tea polyphenols on free radical initiated and photosensitized peroxidation of human low density lipoprotein [J]. Chemistry and Physics of Lipids, 2000, 106(1): 53-63. [109] Dimmeler S, Haendeler J, Zeiher A M. Regulation of endothelial cell apoptosis in atherothrombosis [J]. Current Opinion in Lipidology, 2002, 13(5): 531-536. [110] Wintergerst E S, Jelk J, Rahner C, et al. Apoptosis induced by oxidized low density lipoprotein in human monocyte‐derived macrophages involves CD36 and activation of caspase-3 [J]. The FEBS Journal, 2000, 267(19): 6050-6059. [111] Salvayre R, Auge N, Benoist H, et al. Oxidized low-density lipoprotein-induced apoptosis [J]. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2002, 1585(2): 213-221. [112] Jeong Y J, Choi Y J, Kwon H M, et al. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids [J]. British Journal of Nutrition, 2005, 93(5): 581-591. [113] Liu M L, Yu L C. Potential protection of green tea polyphenols against ultraviolet irradiation-induced injury on rat cortical neurons [J]. Neuroscience letters, 2008, 444(3): 236-239. [114] Yan X, Li J. GW28-e0321 Epigallocatechin-3-gallate inhibits H2O2-induced apoptosis in Mouse Vascular Smooth Muscle Cells via 67 kD Laminin Receptor [J]. Journal of the American College of Cardiology, 2017, 70(Sup 16): C57-C58. DOI: 10.1016/j.jacc.2017.07.196. [115] Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2004, 24(6): 998-1005. [116] Vanhaesebroeck B, Leevers S J, Panayotou G, et al. Phosphoinositide 3-kinases: a conserved family of signal transducers [J]. Trends in Biochemical Sciences, 1997, 22(7): 267-272. [117] Dimmeler S, Zeiher A M. Nitric oxide-an endothelial cell survival factor [J]. Cell death and differentiation, 1999, 6(10): 964-968. [118] Jacob R A, Gretz D M, Taylor P C, et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women [J]. The Journal of nutrition, 1998, 128(7): 1204-1212. [119] Liu S, Sun Z, Chu P, et al. EGCG protects against homocysteine-induced human umbilical vein endothelial cells apoptosis by modulating mitochondrial-dependent apoptotic signaling and PI3K/Akt/eNOS signaling pathways [J]. Apoptosis, 2017, 22(5): 672-680. [120] 蔡宏文, 毛威. 动脉粥样硬化斑块内新生血管中西医治疗进展[J]. 中华中医药学刊, 2015, 33(5): 1168-1170. [121] Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia [J]. Journal of Neuroscience, 2001, 21(19): 7724-7732. [122] Park J W, Hong J S, Lee K S, et al. Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia [J]. The Journal of Nutritional Biochemistry, 2010, 21(11): 1038-1044. [123] Cheng X W, Kuzuya M, Nakamura K, et al. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2005, 25(9): 1864-1870. [124] Bolduc V, Baraghis E, Duquette N, et al. Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr?/?: hApoB+/+ mice and improves cerebral blood flow [J]. American Journal of Physiology-Heart and Circulatory Physiology, 2012, 302(6): H1330-H1339. [125] Cheng X W, Kuzuya M, Sasaki T, et al. Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression [J]. Cardiovascular Research, 2004, 62(3): 594-602. [126] 王贤波, 成浩, 赵芸, 等. 茶叶中EGCG对小鼠抗凝血作用实验研究[J]. 茶叶科学, 2011, 31(6): 532-536. [127] 房磊, 王捷熙, 刘敏霞, 等. 负载表没食子儿茶素没食子酸酯对血小板功能与凋亡等影响[J]. 中国实验血液学杂志, 2011, 19(3): 764-768. [128] Kang W S, Lim I H, Yuk D Y, et al. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate [J]. Thrombosis research, 1999, 96(3): 229-237. [129] Lill G, Voit S, Schr?r K, et al. Complex effects of different green tea catechins on human platelets [J]. Febs Letters, 2003, 546(2): 265-270. [130] Ok W J, Cho H J, Kim H H, et al. Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner [J]. Journal of Atherosclerosis and Thrombosis, 2012, 19(4): 337-348. [131] Chen X Q, Wang X B, Guan R F, et al. Blood anticoagulation and antiplatelet activity of green tea (-)-epigallocatechin (EGC) in mice [J]. Food & function, 2013, 4(10): 1521-1525. [132] Choi J H, Chang H W, Rhee S J. Effect of green tea catechin on arachidonic acid cascade in chronic cadmium‐poisoned rats [J]. Asia Pacific journal of clinical nutrition, 2002, 11(4): 292-297. [133] Steptoe A, Gibson E L, Vuononvirta R, et al. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial [J]. Atherosclerosis, 2007, 193(2): 277-282. [134] Duffy S J, Vita J A, Holbrook M, et al. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease [J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2001, 21(6): 1084-1089. [135] Rashidi B, Malekzadeh M, Goodarzi M, et al. Green tea and its anti-angiogenesis effects [J]. Biomedicine & Pharmacotherapy, 2017, 89: 949-956. [136] Jain R K, Finn A V, Kolodgie F D, et al. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization [J]. Nature Reviews Cardiology, 2007, 4(9): 491-502. [137] Ahn H Y, Hadizadeh K R, Seul C, et al. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB–induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation ofsis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172) [J]. Molecular Biology of the Cell, 1999, 10(4): 1093-1104. [138] Lin C M, Hou S W, Wang B W, et al. Molecular mechanism of (-)-epigallocatechin-3-gallate on balloon injury-induced neointimal formation and leptin expression [J]. Journal of Agricultural and Food Chemistry, 2014, 62(6): 1213-1220. [139] Hofmann C S, Sonenshein G E. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53 [J]. The FASEB Journal, 2003, 17(6): 702-704. [140] Kavantzas N, Chatziioannou A, Yanni A E, et al. Effect of green tea on angiogenesis and severity of atherosclerosis in cholesterol-fed rabbit [J]. Vascular Pharmacology, 2006, 44(6): 461-463.